Business UpdateMay 7, 2026, 04:02 PM
Acumen Pharma to Present at Bank of America Health Care Conference
AI Summary
Acumen Pharmaceuticals, Inc. announced that its management will participate in a fireside chat at the Bank of America Securities 2026 Health Care Conference. The event is scheduled for May 14, 2026, and a live webcast will be accessible via the company's investor relations website. Acumen is a clinical-stage biopharmaceutical company focused on developing therapeutics for Alzheimer's disease, with its lead candidate sabirnetug currently in a Phase 2 clinical trial.
Key Highlights
- Acumen Pharmaceuticals management to participate in a fireside chat at the Bank of America Securities 2026 Health Care Conference.
- The event is scheduled for Thursday, May 14, 2026, at 8:55 a.m. PT/11:55 a.m. ET.
- A live webcast will be available on www.acumenpharm.com under the Investors tab.
- The webcast will be archived for 90 days following the event.
- Acumen is developing sabirnetug (ACU193) for Alzheimer's disease, currently in Phase 2 ALTITUDE-AD trial.
- The company is also exploring a subcutaneous formulation of sabirnetug and an Enhanced Brain Delivery (EBD") therapy.
Price Impact
More from ABOS